Aditxt, Inc. 8-K

What Happened

• On June 22, 2026, Aditxt, Inc. (the “Company”) filed an 8-K reporting Amendment No. 1 to a Note Purchase Agreement among Aditxt, its wholly owned subsidiary Ignite Proteomics LLC (“Ignite”), and the investors. The amendment increases the aggregate original principal amount of the newly issued series of senior secured convertible notes to $6,254,355.17.
• Under the amended agreement, Aditxt and Ignite issued and sold additional Notes with an original principal amount of $769,230.77 for a cash purchase price of $500,000 paid by the investors.

Key Details

• Amendment date: June 22, 2026 (Purchase Agreement originally dated June 3, 2026).
• Additional Notes issued: $769,230.77 in original principal; purchase proceeds received: $500,000 in cash.
• Total aggregate original principal after amendment: $6,254,355.17.
• Security: the Notes (new and previously issued) are secured by a perfected security interest in substantially all assets of Ignite and its subsidiaries and by a pledge of Aditxt’s equity in Ignite.

Why It Matters

• The company received $500,000 in cash from investors, providing immediate financing. At the same time, these are senior secured convertible notes, which create senior debt obligations secured by Ignite’s assets and Aditxt’s equity in Ignite.
• Because the instruments are convertible, they may affect Aditxt’s capitalization if and when conversion features are exercised; investors should review the full Note and Purchase Agreement (filed as exhibits to prior and current 8-Ks) for conversion terms, interest, maturity and other material provisions.
• The filing also includes disclosure under Item 3.02 (unregistered sales of securities) and Item 7.01 (Regulation FD). Retail investors should read the full agreements and related 8-K exhibits for complete terms before drawing conclusions about dilution or credit exposure.